May 2020 – Page 2 – Policy & Medicine

FDA Publishes Final Guidance on Competitive Generic Therapies

CMS Finalizes Guidance on Pharmaceutical Coupons and Cost Sharing

CMS Launches Program to Lower Insulin Costs

Florida Cancer Specialists Admits to Antitrust Conspiracy

The Impact of COVID-19 on the Hospitality Industry

Teva Settles AKS Allegations

USAO Sues Spinal Device Company and Executives Over Kickbacks

FDA COVID-19 Special Emergency Program for Accelerating Research and Development

Managing Pharma and Medical Device Ethics and Compliance Function Remotely

International Academy for CPD Accreditation Proposed Guidelines for Global Accreditation Standards